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Advanced cancer: nutritional impact and the importance
of integrating palliative care in a public health service
Câncer avançado: impacto nutricional e a necessidade de integração
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ABSTRACT
Background: Cancer patients usually require palliative care. One of the reasons for this is malnu-
trition, which is common in these patients, affecting their prognosis and quality of life. Data on
nutritional care in palliative care are still scarce. Objective: To characterize the diagnosis and
nutritional care in palliative care cancer patients hospitalized in a public health setting. Methods:
Descriptive retrospective cohort study on clinical, laboratory, and nutritional data obtained from
medical records of cancer patients in palliative care. Results: A total of 128 admissions of cancer
patients in palliative care were analyzed. Main primary cancer sites were in digestive, urologic and
pulmonary systems. Mean age was 64.3±16.6 years. Patients were clinically and nutritionally
compromised – mean performance status of 17.77±7.15, hemoglobin 9.6±2.37U/dL, albumin
2.64±0.64g/dL, C-reactive protein 125.37±68.37ml/L, and 60.8% of malnutrition (mean BMI of
20.19±5.57kg/m2). Oral route was the main route of administration (62.5%) and analysis of agree-
ment revealed nutritional provision in excess of estimated daily requirements. No association was
found between fasting condition, hospitalization outcome (death) and nutritional diagnosis (p=0.51).
Conclusions: These cancer patients received palliative care just at the end stage of life, when most
of them were malnourished, symptomatic, without specific oncologic treatment, and with a poor
performance status. There was a preference for oral nutritional therapy, however, energy and pro-
tein supply were higher than the estimated nutritional requirements. The realization of fasting during
hospitalization in the moments before death was not associated with the patient’s outcome.
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RESUMO
Introdução: Pacientes com câncer necessitam de cuidados paliativos. Uma das razões para isso é
a desnutrição, frequentemente observada nesses pacientes, afetando seu prognóstico e qualidade
de vida. No entanto, dados sobre a atenção nutricional em cuidados paliativos ainda são escassos.
Artigo original
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INTRODUCTION
It is estimated that 14 million people are
diagnosed with cancer in the world every year,
and approximately 8.2 million died of cancer in
20121. The incidence of cancer is 11 times greater
in the elderly2, and approximately 60% of the
cases diagnosed and 70% of deaths from cancer
occur in individuals older than 65 years3.
 According to the World Health Organization
(WHO) report, more than 19 million adults require
palliative care, and cancer accounts for 34% of
the underlying diseases in this population4.
Palliative care is defined by the WHO as an
approach aimed at improving the quality of life of
patients and their families facing health problems
that can threaten an individual’s life continuity
through the prevention and relief of suffering5.
Cancer is associated with deterioration of
nutritional status that can progress to severe
malnutrition depending on tumor extension, his-
tological subtype, adverse events to treatment,
and intrinsic characteristics of patients6,7. This
reflects an imbalance between nutritional and
tumor requirements, and direct and indirect ef-
fects of oncologic therapy on one side of the scale,
and nutrient availability in the body on the other
side 8. This culminates in malnutrition, that directly
affects patients’ prognosis6,8.
Despite the direct association between nu-
trition and quality of life, there is a gap in the
literature regarding the existence and application
of guidelines on nutritional care in palliative care
patients. This is also evident in the context of
public health services, in which nutritional assist-
ance is usually provided late, in attempt to re-
verse an already established malnutrition and
debilitating symptoms. There are few available
data on the use of nutritional therapy as a rou-
tine practice in palliative care patients9.
Understanding of how nutritional care has
been provided to palliative care cancer patients
may contribute to the development of a more
adequate approach to this type of patient. There-
fore, this study aimed at characterizing nutritional
therapy, nutritional diagnosis, and metabolic
changes in hospitalized cancer patients in pallia-
tive care in a public health setting.
METHODS
This was a descriptive, retrospective cohort
study of palliative care cancer patients who re-
ceived nutritional care during hospitalization at
Objetivo: Caracterizar o diagnóstico e o cuidado nutricional em pacientes em cuidados paliativos
hospitalizados em um serviço de saúde pública. Métodos: Estudo de coorte retrospectivo descritivo
sobre dados clínicos, laboratoriais e nutricionais obtidos de prontuários de pacientes oncológicos em
cuidados paliativos. Resultados: Foram analisadas 128 internações de pacientes oncológicos em
cuidados paliativos. Os principais sítios tumorais primários estavam nos sistemas digestivo, urológi-
co e pulmonar. A média de idade foi de 64,3 ± 16,6 anos. Os pacientes estavam clínica e nutricional-
mente comprometidos - desempenho médio de 17,77 ± 7,15, hemoglobina 9,6 ± 2,37 U/dL, albumina
2,64 ± 0,64 g/dL, proteína C-reativa 125,37 ± 68,37 ml/L e 60,8% de desnutrição (IMC médio de
20,19 5,57 kg/m2). A via oral foi a principal via de administração (62,5%) e a análise de concor-
dância revelou o suprimento nutricional em excesso às necessidades diárias estimadas. Não foi
encontrada associação entre condição de jejum, desfecho da hospitalização (morte) e diagnóstico
nutricional (p = 0,51). Conclusões: Esta população de pacientes oncológicos recebeu cuidados
paliativos no estágio final de vida, quando a maioria estava desnutrida, sintomática, sem tratamen-
to oncológico e com baixo desempenho funcional. Houve a preferência pelo uso da via oral para a
realização da terapia nutricional, contudo, observou-se fornecimento energético e proteico superior
às necessidades nutricionais estimadas. A realização de jejum durante o período de internação
hospitalar que antecede o óbito não foi associada com o desfecho dos pacientes.
Palavras-chave: Cuidados Paliativos. Câncer. Estado Nutricional. Terapia Nutricional. Nutrição.
Saúde Pública.
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the department of palliative care of Americo
Brasiliense Hospital in the period from June 2011
to June 2013. Patient’s data were collected from
medical records. A total of 805 cancer patients in
palliative care were admitted in this period, and
the first 128 admissions were included in this
study.
Data collection
Clinical laboratory data and nutritional data
were collected from patients’ medical records, as
described below:
• Clinical laboratory data: time of hospitalization,
sociodemographic characteristics, comorbidities,
symptoms, performance status (Karnofsky Per-
formance Status, KPS) at admission, laboratory
data, medications and oncologic diagnosis;
• Nutritional data: nutritional care in the first 72
hours of admission; measured or estimated10
current body weight (kg); measured or esti-
mated11 current height, body mass index (BMI)
(weight [kg]/height2 [m]) and respective cutoff
points for underweight, normal weight, over-
weight and obesity12; arm circumference (AC)
(cm) and calculation of percentage adequacy13.
Patients were classified into malnourished, at
nutritional risk, normal weight, at risk of over-
weight, overweight and obese. In addition, the
percentage of weight loss was calculated and
classified as: significant loss or severe weight
loss over time14.
In addition, patients’ nutritional require-
ments were calculated as follows:
• Basal metabolic rate (BMR) using the Harris-
Benedict equation (1919)15, total energy ex-
penditure (TEE) calculated by three different
methods – by multiplying BMR by activity factor,
stress factor, temperature factor16 (“TEE – 1” in
this study ), by multiplying patient’s current body
weight by 25 (“TEE – 2”) or 35 (“TEE – 3”), ac-
cording to the Brazilian National Cancer Insti-
tute17 recommendations;
• Minimum and maximum recommended daily pro-
tein intake – 1.0 to 1.5g of protein / kg of cur-
rent body weight / day17;
Information of patients’ diet:
• Feeding routes – oral, enteral and/or parenteral;
• Characteristics and composition of diet – diet
composition was analyzed using the Brazilian
Food Composition Table18. Composition of pre-
packed formulas administered orally or enterally
was obtained by the manufacturer.
• Period (hours) of the hospital patient’s fast,
based on the medical prescription information
and the evolution of the multidisciplinary team.
Data analysis
Collected data were transferred to a spread-
sheet and analyzed using the SAS software (SAS
Institute, 1999). The Kruskal-Wallis test followed
by Dunn’s test was used for comparisons involv-
ing three or more independent groups. Associa-
tions between two qualitative variables were ex-
amined using the Fisher’s exact test. The coeffi-
cient of agreement proposed by Lin19 was also
used. A p<0.05 was set as statistically significant.
Ethical issues
The study was approved by the Research
Ethics Committee of the General Hospital of
Ribeirao Preto Medical School, University of Sao
Paulo (approval number 497.327).
RESULTS
Data of 128 hospitalized oncology patients
in palliative care were analyzed. The majority of
patients were older (median age 64 years); clini-
cal demographic data are described in Table 1.
The most prevalent symptoms during hos-
pitalization were: pain (60.9%), constipation
(53.1%), anorexia, (43.7%) and dyspnea (42.2%).
Patients’ general well-being at admission
was evaluated by the Karnofsky scale. Mean KPS
was 19.77 ± 7.15, with a median of 20 (10 - 40),
indicating that patients were very sick, requiring
hospitalization and active supportive treatment.
With respect to laboratory data, mean val-
ues of serum hemoglobin and albumin (9.6 ± 2.37
U/dL and 2.64 ± 0.64 g/dl, respectively) were lower
than reference values. Increased serum levels
were found for creatinine (1.37 ± 1.33 mg/dL),
urea (76.96 ± 60.2 ml/dL), direct bilirubin (1.87 ±
3.28 ml/dL), total bilirubin (3.45 ± 5.81 mg/dL),
reactive C protein (125.37 ± 68.37 ml/L), aspar-
tate aminotransferase (110.64 ± 143.82 U/L), and
alanine transaminase (56.82 ± 60.22 U/L).
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Table 1
Clinical and demographic characteristics of patients (n=128)
Characteristics
Results
nº (%)
Age (years)
Mean ± standard deviation 64.27 ± 16.64
Median 64.5
Sex
Male 73 (57.03%)
Female 55 (42.97%)
Hospital stay duration (days)
Mean ± Standard deviation 12.77 ± 12.88
Median 8.0
Reason for hospitalization
Control of signs and symptoms 63 (49.22%)
Decrease in general well-being 20 (15.63%)
Infection 24 (18.75%)
End-of-life care 21 (16.41%)
Outcome of hospitalization
Death 83 (64.85%)
Hospital discharge 43 (33.59%)
Primary tumor site
Digestive system 41 (32.03%)
Head and neck 20 (15.63%)
Urologic system 20 (15.63%)
Pulmonary system 19 (14.84%)
Gynecologic / breast 17 (13.28%)
Others 11 (8.59%)
Metastasis 77 (60.16%)
Metastatic sites
Visceral 57 (44.53%)
Bones 30 (23.44%)
Brain 18 (14.06%)
Lymph node 9 (7.03%)
Previous oncologic therapy 73 (57.03%)
Chemotherapy / Hormonal therapy 57 (44.53%)
Surgery 40 (31.25%)
Radiotherapy 36 (28.13%)
Comorbidities 84 (65.63%)
Systemic arterial hypertension 49 (38.28%)
Renal failure 29 (22.66%)
Depressive disorder 22 (17.19%)
Diabetes Mellitus 18 (14.06%)
Others 36 (28.13%)
Legend: n = number of patients; % = percentage
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Another outcome measured was the rou-
tine use of medications. The most frequently used
were opioids (34.4%) and non-opioid analgesics
(20.3%) for oncologic pain (Table 2).
Body weight was measured in 96 patients,
with a mean of 53.09 ± 13.96 Kg, and a severe
weight loss (22) was identified in 25% of these
patients. Mean BMI was 20.19 ± 5.57 Kg/m2, with
60.8% of patients classified as malnourished. This
was significantly associated (p<0.01) with the
percentage of weight loss and values of AC.
There was a statistically significant asso-
ciation between nutritional status (categorized by
BMI) and the percentage of previous weight loss
(p value <0.01), arm circumference (p value
<0.01); but not between nutritional diagnosis and
the length hospitalization (p value = 0.62), ac-
cording to the table 3.
Regarding nutritional approach, 62.5% of
patients received soft (38.7%) or pureed (34.7%)
diet. Also, 46.1% of these patients received an
individualized diet according to their desire and
preference. Oral nutritional supplementation was
performed in 25% of patients, mostly with a 1.5
caL/mL formula. Fifty-three patients received en-
teral diet during hospitalization, mainly (49.1%)
Table 2
Classes of medications used by the study
population
Classes of medications n (%)
Non-opioid analgesics  26 (20.31%)
Antihistamines  2 (1.56%)
Antibiotics  18 (14.06%)
Antidepressants  22 (17.19%)
Antiemetic agents  14 (10.94%)
Anti-inflammatories  9 (7.03%)
Corticosteroids  16 (12.5%)
Diuretics  20 (15.63%)
Appetite stimulants  3 (2.34%)
Laxatives  10 (7.81%)
Opioids  44 (34.38%)
Nutritional / vitamin supplements  8 (6.25%)
Table 3
Analysis of association between nutritional diagnosis and the percentage of previous weight
loss, arm circumference, hospitalization period and hospitality fast.
Standard
Nutritional Status N Mean Sdeviation Median P value
Percentage of previous weight loss
Malnutrition 58 28,65 11,33 26,13 *
Normal weight 28 13,7 7,12 11,6 § <0.01
Overweight 5 0 0 0
Obesity 5 6,99 0,68 6,99 §
Arm circumference (centimeters)
Malnutrition 58 21,45 3,37 21 *
Normal weight 28 27 2,24 27 § <0.01
Overweight 5 30,8 2,89 31,5 §
Obesity 5 34,13 3,57 34 §
Period of hospitalization (days)
Malnutrition 58 15,1 13,34 10
Normal weight 28 15,5 14,53 10,5 0.62
Overweight 5 13 9,64 10
Obesity 5 21,2 13,33 21
Fasting during hospitalization
Death (N) Hospital discharge (N) P value
Nutritional Status 9 11
Malnutrition 1 2 0.51
Normal weight 1 1
Overweight 1 1
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a 1.0 caL/mL formula. No patient received
parenteral nutrition during the study period.
Another aspect analyzed in our study was
fasting period. Of the 128 patients included, 61
(47.7%) patients fasted during hospital stay
(mean of 22.44 ± 26.50 hours [0.43 to 110.42
hours]), mainly during the days prior to death.
Eight patients remained fasted throughout their
hospitalization period with a mean of 1.63 ± 0.74
days [1 to 3 days]. Patients total fasting time
were 22.53 ± 19.80 hours, representing 58.59 ±
41.8% of the total hospitalization period.
Considering 61 patients who were fasted
during hospitalization, 45 had a nutritional sta-
tus diagnosis according to BMI. When analyzing
the data, we identify that there was no statisti-
cally significant association (p=0.51) between the
fasting and the patient’s outcome, even consid-
ering their nutritional status diagnosis (Table 3).
Means of energy, macronutrients (carbohy-
drates, proteins and fats) and dietary fiber pro-
vided during patients’ hospital stay was also
analyzed. Mean energy delivered was 1819 ± 699
Kcal/day (53.97 ± 8.82% carbohydrates, 16.36 ±
2.31% of proteins, 29.37 ± 6.30% of fats) and
17.29 ± 7.56 gram of fiber daily. Dietary protein
and energy provided was greater than estimated
requirements (Table 4).
A weak agreement (Lin’s concordance cor-
relation coefficient) was found between estimated
nutritional requirements and the amounts of en-
ergy and protein supplied, as detailed in Table 5.
Table 4
Comparative analysis of dietary energy and protein provided with estimated nutritional
requirements
Variables Mean Standard deviation Median
% Energy provided /day vs. TEE-1 114.55 43.62 113.16
% Energy provided /day vs. TEE-2 192.39 87.74 168.96
% Energy provided /day vs. TEE-3 109.94 50.14 96.55
% Protein provided /day vs. minimum recommended
amount /day 163.4 81.79 142.76
% Protein provided /day vs. maximum recommended
amount /day 96.99 52.28 84.95
TEE: total energy expenditure
Table 5
Agreement analysis of estimated energy and protein requirements with the amount delivered
to the study population
ccc 95% C I
BMR vs. total energy provided (Kcal) 0.03 -0.02 0.08
TEE – 1 vs. total energy provided (Kcal) 0.08 -0.05 0.21
TEE – 2 vs. total energy provided (Kcal) 0.02 -0.04 0.08
TEE – 3 vs. total energy provided (Kcal) 0.08 -0.11 0.26
Minimum recommended protein level (g/day) vs. total provided (g) 0.02 -0.07 0.11
Maximum recommended protein level (g/day) vs. total provided (g) 0.06 -0.12 0.24
BMR: basal metabolic rate (Kcal/day); TEE: total energy expenditure (Kcal/day); ccc: Lin’s concordance correlation coefficient; CI:
confidence interval
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DISCUSSION
Analysis of clinical, oncological, and nutri-
tional aspects of a population of cancer patients
in palliative treatment revealed interesting par-
ticularities that may contribute to the remodeling
of palliative care processes and clinical routines
in the context of public health. Most patients were
elderly, with diagnosis of advanced-stage cancer,
without specific treatment, symptomatic and de-
bilitated, with significant metabolic changes, high
prevalence of malnutrition and delayed access to
palliative care.
In agreement with previous studies, socio-
demographic characteristics of the sample re-
flected the current epidemiological transition, with
increasing demand for palliative care in elderly
patients9,20,21. In addition, the presence of weak,
symptomatic patients in advanced stage of can-
cer disease at hospital admission is corroborated
by the high percentage of in-hospital death and
low KPS in our sample.
These findings suggest a delayed referral
to palliative care services, whose beneficial ef-
fects on quality of life and well-being, provided
by patient- and family-centered care, are limited
by patients’ severity and risk of imminent death.
Similar conclusions were reported by other stud-
ies that investigated difficulties encountered by
patients in getting access to palliative care22,23.
Considering cancer specific treatments as
chemotherapy; target-therapy; radiotherapy and
surgery, only 57% of patients received at least
one treatment. According to a North American
paper, they verified that only 12.3% of the
113,885 patients with invasive cancer did not re-
ceive any cancer treatment and, the fact of not
receiving oncologic treatment increased signifi-
cantly with age and cancer stage. In fact, patients
with stage II or III disease were twice as likely to
not receive treatment as those with early-stage
disease (stage I), and stage IV cancers were six
times more likely to not be treated24. Thus, the
high percentage of cancer patients with inad-
equate treatment access verified in our study
suggests that patients are mostly admitted for
end-of-life care, with a delayed diagnosis and lim-
ited access to tertiary services with cancer treat-
ment and assistance.
This situation is even worse taking into ac-
count characteristics of the elderly population,
including higher incidence of cancer and chronic
diseases. Also, these patients may have low edu-
cational attainment and low income, and thereby
rely on public health services25.
A high prevalence of metastatic patients
(60.2%) with comorbidities (65.6%), as observed
in our sample, makes the action of multidisciplinary
teams and use of specific therapies difficult, in
addition to increase the frequency of recurrent
hospitalization, particularly in the elderly26,27.
The requirement of hospitalization for con-
trol of symptoms, particularly cancer-related pain,
resulting from the progression of oncologic dis-
ease26,27, has been associated with decreased
quality of life26 and impaired nutritional status6,28,29
in palliative care patients. Opioids and non-opioids
analgesics were the most commonly used drugs
to treat cancer-related pain. This symptom in-
volves not only physical manifestations, but also
psychological, spiritual and social spheres that are
carefully addressed by the palliative care team,
in combination with standard drug treatment,
since early stages of cancer diagnosis. However,
in terminal stages of the disease, even total pain
is treated with medications that do not control all
symptom dimensions28,30.
In our patients, altered biochemical param-
eters characterize a chronic consumptive disease
of inflammatory stress (anemia, increased inflam-
matory tests, decreased albumin) associated with
organ failure (e.g. kidney, liver), that are directly
correlated with lower survival rates, as previously
described28,30.
In our study, 60.8% of patients had a diag-
nosis of malnutrition according to BMI. Malnutri-
tion is commonly observed in patients with can-
cer and negatively affects functional state, immune
response, quality of life and survival28,29. It is di-
rectly associated with death in more than 20% of
cancer patients, particularly when diagnosed in
the terminal phase and in patients with low func-
tionality29,30.
Among anthropometric parameters, weight
loss prior to admission and AC measurements
corroborate nutritional deficits in palliative care
patients, and are associated with in-hospital
mortality31,32.
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With respect to the route of diet adminis-
tration, we found that oral route was predomi-
nant in our study population. Oral nutrition is the
route of choice for nutritional therapy; it is directly
correlated with benefits to patients’ quality of life,
and stimulates the pleasure of eating33. Enteral
nutrition was also reported in palliative care pa-
tients6,28,34. Indication of this route of nutrition
support should consider the potential risks and
benefits of nutritional therapy to the patient, as
well as its impact on survival and quality of
life6,34,35.
Estimates of energy, macronutrients and
fibers delivered to patients corroborate the re-
sults reported by other authors36. Changes and
decline in energy and nutrient intake are in are
commonly observed in cancer patients, especially
during the end of life stage37. Under these cir-
cumstances, nutritional intake did not reach the
current recommended levels for energy and pro-
tein in most advanced cancer patients; worsen-
ing prognosis and quality of life38.
Therefore, it is essential to associate the
evaluation and adequacy of the quantity and qual-
ity of nutritional intake (calories, macronutrients
and fibers) with clinical signs and symptoms of
nutritional status to obtain an adequate nutritional
assistance, according to the real needs of the
patient during the different phases of cancer dis-
ease6. However, it is important to remember that
the retrospective nature of our study is a limita-
tion, as we could not quantify the actual consump-
tion in relation to the amount provided.
It is important to be aware of the effects of
overfeeding in palliative care patients. Water and
nutrient excess can cause an overload that may
result in patients’ discomfort34. Several studies
have reported that provision of macronutrients
in amounts greater than patients’ requirements
offers no benefits in treatment response, survival
rate or patients’ well-being, and can even be del-
eterious to their quality of life39,40.
However, analyses of agreement between
the amount of nutrients provided and nutritional
requirements calculated for each patient showed
a disagreement between them, with provision in
excess of estimated needs. This finding calls for
the importance of the individualization of nutri-
tional therapy according to patients’ actual needs.
Individualization of dietary prescription may im-
prove acceptance of the diet and reduce food
waste, restore the feelings of pleasure and sat-
isfaction of eating, and promote benefits to qual-
ity of life29.
Fasting in palliative care of patients in end-
of-life stage is controversial. The decision to with-
draw nutritional support has been questioned due
to the fact that both nutrition and hydration are
considered basic necessities of human life34,41. In
our study, 61 patients spent some days in fast-
ing conditions during hospitalization. In addition,
progressive decrease in oral intake may be asso-
ciated with cachexia-anorexia syndrome, which is
quite common in advanced cancer and other
chronic conditions30.
The decision to withdraw nutrition support
from these patients, therefore, should be dis-
cussed by healthcare providers, taking into ac-
count patients’ and families’ desire and expecta-
tions, patients’ health status and prognosis, their
nutritional requirements and quality of life41.
In addition, we found no significant asso-
ciation between fasting and hospitalization out-
come, even when considering the diagnosis of
nutritional status. In a qualitative study42, a vol-
untary, gradual decrease in food intake was ob-
served in palliative care patients at the end of
life. The authors reported that no sign of physical
suffering attributable to the decline in oral intake
was identified.
The major strength of this study was that
we presented data from patients with cancer in
palliative care in the public health scenario, bring-
ing up for discussion not only organizational is-
sues (including the flow of healthcare delivery)
but also the need for nutritional protocols spe-
cific for palliative care patients, that may contrib-
ute to the construction of knowledge by healthcare
professionals and provide benefits to routine
health care practice for this population.
CONCLUSION
Advanced cancer has a significant negative
impact on quality of life, resulting from worsening
of symptoms associated with tumor progression
/ invasion, toxicity of cancer treatment, aggrava-
tion of previous comorbidities and progressive
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functional decline. In this context, a comprehen-
sive palliative care is crucial to fulfill patients’
needs that are beyond the physical realm.
Most of our study population was malnour-
ished, with important nutritional deficits. The of-
fer of energy and macronutrients was a priority
in nutritional therapy, and exceeded estimated
nutritional requirements. Fasting was not corre-
lated with death or nutritional deficit at the end
stage of life.
Malnutrition, impairment of body energy
store, metabolic changes and the presence of
symptoms that affect food intake were detected
in palliative care cancer patients. This highlights
the importance of individualization of dietary plan
and its relevance and impact on palliative care.
Thus, nutritional care should provide ad-
equate amounts of nutrients, respecting patients’
nutritional needs, desire and preferences, as well
as the decrease in food intake at the end stage of
life.
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